Delivery Order SPE2DB22D3004-SPE2DB25FPG15

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INFANRIX DTAP SYRINGE 0.5ML vaccines. This $1,204.90 contract has a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor for this order, which is a child contract under a potential $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA to supply...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,636.31 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of INFANRIX DTAP SYRINGE 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The $2,949.00 fixed-price contract has a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the company to...
This is a $2,064.30 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The delivery order has an ultimate completion date of August 2, 2024 and is a firm-fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $12,323.40 to Amerisourcebergen Drug Corp for the supply of 0.5 mL PEDIARIX vaccine syringes. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pediatric vaccine product. The firm fixed price delivery order has a ceiling value of $2,824.94 and a period of performance through April 2, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp that allows for the delivery of a...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6HFK, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,335.06 firm fixed-price delivery order is for the procurement of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of INFANRIX DTAP SYRINGE 0.5ML, a childhood vaccine, to support the Department of Defense's medical treatment programs and facilities worldwide. The order has a firm fixed price of $1,474.50 and a completion date of May 23, 2024. AmerisourceBergen, through its...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,949.00 firm-fixed-price delivery order contract covers the supply of INFANRIX DTAP SYRINGE 0.5ML medical products. The contract has an ultimate completion date of August 21, 2024. While the original solicitation was not provided, the contract appears to be part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product. The contract has a firm fixed price of $2,115.27 and a period of performance through September 26, 2024. It is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPG15
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP vaccine syringes. The contract has a ceiling value of $1,363.72 and a period of performance through January 28, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/28/25, 9:49 AM